Eptiday 0.75mg Injection
Marketer
G C Chemie Pharmie Limited
Salt Composition
Eptifibatide (0.75mg)
Overview Eptiday 0.75mg Injection
Eptday 0.75mg Injection is an anticoagulant preventing the development of dangerous blood clots. It's employed in acute myocardial infarction treatment and to hinder clot formation during cardiac angioplasty (a procedure enhancing coronary blood flow). Administration of Eptday 0.75mg Injection requires physician oversight; dosage and treatment length are determined individually. Concurrent use with all other prescribed medications should continue. Thrombocytopenia and heightened bleeding risk are potential adverse effects. Report any petechiae or blood in emesis, urine, or feces immediately. Hypotension is another possible side effect. Your physician will discuss the risks and advantages before treatment. Caution is warranted in certain patients. Prior to administration, disclose any bleeding disorders, hepatic or renal impairment, pregnancy, breastfeeding, or other medications currently in use.
Primary Ingredients of Eptiday 0.75mg Injection
No text provided. Please provide the text you wish me to rewrite.
Uses of Eptiday 0.75mg Injection
Thrombosis prophylaxis | Myocardial infarction prevention
Major Benefits of Eptiday 0.75mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Eptiday 0.75mg Injection:
- Bleeding
- Decreased blood pressure
How to use Eptiday 0.75mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Eptiday 0.75mg Injection works:
Eptiday 0.75mg Injection is an antithrombotic agent that inhibits platelet aggregation, thus reducing the risk of dangerous thrombus development.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Eptiday 0.75mg Injection lacks established safety data. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Administration of Eptiday 0.75mg Injection during gestation is typically viewed as safe. Preclinical trials in animals have revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Eptiday 0.75mg Injection to breastfeeding mothers requires careful consideration. Lactation should cease until maternal treatment concludes and the medication is fully cleared from the maternal system.
DrivingNOT RELEVANT
Eptiday 0.75mg Injection is exclusively administered in the inpatient setting.
KidneyCAUTION
Patients with impaired kidney function should use Eptiday 0.75mg Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised. Eptiday 0.75mg Injection is contraindicated in individuals with severe kidney disease.
LiverCONSULT YOUR DOCTOR
Data regarding Eptiday 0.75mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised. Eptiday 0.75mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Eptiday 0.75mg Injection :
Omit a scheduled Eptiday 0.75mg Injection? Seek medical advice immediately.
Facts to Know About Eptiday 0.75mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Peptide and Amino Acid Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | IIb/IIIa receptor antagonists |
3,018 People bought this recently